Literature DB >> 12160962

Ischemic preconditioning protection against stunning in conscious diabetic sheep: role of glucose, insulin, sarcolemmal and mitochondrial KATP channels.

Hector F del Valle1, Elena C Lascano, Jorge A Negroni.   

Abstract

INTRODUCTION: Sarcolemmal and mitochondrial ATP-sensitive potassium (KATP) channels have been postulated to participate in preconditioning protection against infarction and stunning. However, these structures appear to be altered in diabetes and thus, it would be possible that preconditioning does not develop in diabetic hearts.
OBJECTIVE: The purpose of this study was to know whether early (EP) and late (LP) ischemic preconditioning against stunning develop in conscious diabetic (D) sheep and whether diabetes affects KATP channel function.
METHODS: Male castrated sheep received alloxan monohydrate (1 g) and were ascribed to three experimental groups: control [DC, 12 min of ischemia (i) followed by 2 h of reperfusion (r)], early preconditioning (DEP, six 5 min i-5 min r periods were performed 45 min before the 12 min i) and late preconditioning (DLP, same as DEP except that the preconditioning stimulus was performed 24 h before the 12 min i). Regional mechanics during reperfusion was evaluated by wall thickening fraction (%WTH) and expressed as percentage of basal values (100%), and KATP channel behavior was indirectly assessed by monophasic action potential duration (MAPD) in relation to its sensitivity to glibenclamide blockade (0.1 and 0.4 mg/kg). The results were compared to those obtained in normal (N) sheep. The effects of sarcolemmal and mitochondrial KATP channel blockade on recovery from stunning were assessed by administration of glibenclamide (0.1 and 0.4 mg/kg) and 5-hydroxydecanoate (5-HD, 5 mg/kg i.v.) and/or diazoxide (10 microg/kg/min over 90 min). Whether acute hyperglycemia (H) in normal animals and insulin (I) treatment in diabetic sheep affected preconditioning protection and KATP channel behavior were also evaluated.
RESULTS: Results expressed as mean % recovery of %WTH showed that preconditioning protected against stunning in normal sheep (NC=65+/-3.5, NLP=82+/-6**, NEP=76+/-4*, *P<0.05 and **P<0.01 against NC) while this did not occur in diabetic ones, where DLP (58+/-7.6) afforded a similar recovery to DC (54+/-5) and DEP worsened instead of improving mechanical function (37+/-9, P<0.01 against DC). Acute hyperglycemia did not affect preconditioning development (NEPH=72+/-3 and NLPH=80+/-4) and insulin treatment reverted the lack of early and late preconditioning protection in diabetic hearts (DEPI=72+/-4* and DLPI=76+/-3*, P<0.05 against DC). Sarcolemmal KATP channel behavior appeared altered in diabetic hearts as shown by MAPD in normal sheep (276+10 ms) compared to diabetic ones (365+9 ms, P<0.05) and by the sensitivity to glibenclamide [0.1 mg/kg completely blocked KATP channels in diabetic (P<0.05) but not in normal hearts]. Insulin also restored MAPD in diabetic heart. Mitochondrial KATP channels appeared not to account for the reported results in diabetes, since glibenclamide (%WTH=40+/-4, P<0.01 vs. NC), but not 5HD nor diazoxide affected myocardial functional recovery during reperfusion.
CONCLUSIONS: Sarcolemmal KATP channel dysfunction due to the lack of insulin affords a primary approach to explain the absence of preconditioning protection against stunning in diabetic sheep hearts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12160962     DOI: 10.1016/s0008-6363(02)00468-6

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  18 in total

Review 1.  Preconditioning: a paradigm shift in the biology of myocardial ischemia.

Authors:  Roberto Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-09-08       Impact factor: 4.733

2.  Early preconditioning protection against stunning in conscious sheep. Role of KATP channels.

Authors:  Elena Catalina Lascano; Jorge A Negroni; Héctor F del Valle
Journal:  Mol Cell Biochem       Date:  2009-06-12       Impact factor: 3.396

3.  Role of the cyclooxygenase pathway in the protection against postischemic stunning in conscious sheep.

Authors:  Elena C Lascano; Héctor F Del Valle; Jorge A Negroni
Journal:  Mol Cell Biochem       Date:  2006-05-12       Impact factor: 3.396

4.  Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart.

Authors:  Harlokesh Narayan Yadav; Manjeet Singh; P L Sharma
Journal:  Mol Cell Biochem       Date:  2010-05-30       Impact factor: 3.396

5.  The threshold of admission glycemia as a predictor of adverse events in diabetic and non-diabetic patients with acute coronary syndrome.

Authors:  Taysir S Garadah; Salah Kassab; Qasim M Al-Shboul; Abdulhai Alawadi
Journal:  Clin Med Cardiol       Date:  2009-04-01

6.  Failure to confer cardioprotection and to increase the expression of heat-shock protein 70 by preconditioning with a kappa-opioid receptor agonist during ischaemia and reperfusion in streptozotocin-induced diabetic rats.

Authors:  J S Qi; K W L Kam; M Chen; S Wu; T M Wong
Journal:  Diabetologia       Date:  2004-01-09       Impact factor: 10.122

Review 7.  Protection of the abnormal heart.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

8.  Chronic total artery occlusions in noninfarct-related coronary arteries.

Authors:  Ozcan Ozeke; Mutlu Gungor; Serkan Topaloglu; Dursun Aras; Can Ozer
Journal:  Int J Angiol       Date:  2014-03

9.  Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart.

Authors:  Preeti Ajmani; Harlokesh N Yadav; Manjeet Singh; Pyare L Sharma
Journal:  BMC Cardiovasc Disord       Date:  2011-07-12       Impact factor: 2.298

10.  High glucose regulates the activity of cardiac sarcolemmal ATP-sensitive K+ channels via 1,3-bisphosphoglycerate: a novel link between cardiac membrane excitability and glucose metabolism.

Authors:  Sofija Jovanović; Aleksandar Jovanović
Journal:  Diabetes       Date:  2005-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.